Progyny (PGNY) grants RSUs and stock options to director Dean Lloyd H
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Progyny, Inc. director Dean Lloyd H received new equity compensation consisting of common stock underlying restricted stock units and stock options. He was granted 6,792 shares of common stock underlying restricted stock units, bringing his direct common stock holdings to 26,519 shares.
He was also granted a stock option covering 28,203 shares of common stock at an exercise price of $24.69 per share, expiring on May 20, 2036. Both the restricted stock units and the option will vest on the earlier of May 21, 2027 or the calendar day immediately preceding Progyny’s first annual meeting of stockholders following the grant date, subject to his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Dean Lloyd H
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 28,203 | $0.00 | -- |
| Grant/Award | Common Stock | 6,792 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 28,203 shares (Direct, null);
Common Stock — 26,519 shares (Direct, null)
Footnotes (1)
- Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.
Key Figures
RSU-based common shares granted: 6,792 shares
Common shares held after grant: 26,519 shares
Option shares granted: 28,203 shares
+3 more
6 metrics
RSU-based common shares granted
6,792 shares
Common stock underlying restricted stock units granted to director
Common shares held after grant
26,519 shares
Director’s direct Progyny common stock holdings post-transaction
Option shares granted
28,203 shares
Stock Option (Right to Buy) underlying common stock
Option exercise price
$24.69 per share
Conversion or exercise price for the stock option
Option expiration date
May 20, 2036
Final expiration date of the stock option grant
Vesting date trigger
May 21, 2027
Latest vesting date for RSUs and option, subject to service
Key Terms
restricted stock units ("RSUs"), Stock Option (Right to Buy), vest, annual meeting of stockholders
4 terms
restricted stock units ("RSUs") financial
"Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs")."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with underlying security titled Common Stock."
vest financial
"The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date"
FAQ
What equity awards did Progyny (PGNY) grant to director Dean Lloyd H?
Progyny granted director Dean Lloyd H restricted stock units and stock options. He received 6,792 shares of common stock underlying RSUs and an option for 28,203 shares, providing both immediate stock-based compensation and a longer-term incentive tied to future share price.
What are the terms of the new Progyny (PGNY) stock option grant?
The new stock option covers 28,203 shares of Progyny common stock at an exercise price of $24.69 per share. The option expires on May 20, 2036 and provides the right, but not the obligation, to buy shares at that fixed price if it becomes economically attractive.
When do Dean Lloyd H’s new Progyny (PGNY) RSUs and options vest?
Both the restricted stock units and the stock option vest on the earlier of May 21, 2027, or the calendar day immediately before Progyny’s first annual meeting of stockholders following the grant date, assuming Dean Lloyd H continues to serve through the applicable vesting date.
Is Dean Lloyd H’s equity grant in Progyny (PGNY) an open-market purchase?
No, the Form 4 shows a compensation-related acquisition, not an open-market purchase. The 6,792 RSU-based shares and 28,203 stock option shares were granted at no cost per share as director compensation, with future vesting and, for options, a $24.69 exercise price.